LFMD Stock Overview
Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
LifeMD is a diamond in the making
LifeMD, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.26 |
| 52 Week High | US$9.87 |
| 52 Week Low | US$3.99 |
| Beta | 2.23 |
| 1 Month Change | 64.21% |
| 3 Month Change | 19.88% |
| 1 Year Change | -11.37% |
| 3 Year Change | 291.47% |
| 5 Year Change | 412.25% |
| Change since IPO | 120.27% |
Recent News & Updates
LifeMD Might Run Higher
May 09LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
May 09
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story
May 07
New HRT, GLP-1 And Medicare Programs Will Elevate Care
Apr 23 Expansion in Medicare programs and integration with Gifthealth are set to enhance LifeMD's market reach and boost revenue through improved patient retention.Recent updates
LifeMD Might Run Higher
May 09LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
May 09LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story
May 07New HRT, GLP-1 And Medicare Programs Will Elevate Care
Apr 23 Expansion in Medicare programs and integration with Gifthealth are set to enhance LifeMD's market reach and boost revenue through improved patient retention.
LifeMD is a diamond in the making
Apr 21Telehealth is the future of healthcare in america and around the world. Most people don’t want to wait hours in the hospital or even weeks for an appointment. Telehealth offers those services the sameA Look At The Intrinsic Value Of LifeMD, Inc. (NASDAQ:LFMD)
Mar 31It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks
Mar 08LifeMD: Dilution Ramps Up As Revenue Moves Higher
Feb 01LifeMD, Inc.'s (NASDAQ:LFMD) Intrinsic Value Is Potentially 82% Above Its Share Price
Dec 06LifeMD: A Story I Want A Small Piece Of
Dec 04LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story
Nov 09LifeMD: Are The Commons Too Cheap?
Sep 23LifeMD: Selling WorkSimpli Could Be A Catalyst
Sep 10It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks
Aug 16LifeMD: High Growth GLP-1 Telehealth Play At A Discount
Jul 31LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare
Jun 11LifeMD: Moving Towards Profitability
May 22Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?
Apr 25Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely
Mar 30LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
Mar 13LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability
Jan 22LifeMD: A GLP-1 Play With A Kicker
Jan 11Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?
Jan 05Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper
Jan 05Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?
Dec 03Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump
Apr 17Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week
Nov 17LifeMD launches at-home screening kits for breast, colon cancers
Sep 14LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M
Aug 11Shareholder Returns
| LFMD | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 13.9% | -1.2% | -0.3% |
| 1Y | -11.4% | 11.6% | 8.1% |
Return vs Industry: LFMD underperformed the US Healthcare Services industry which returned 11.6% over the past year.
Return vs Market: LFMD underperformed the US Market which returned 8.1% over the past year.
Price Volatility
| LFMD volatility | |
|---|---|
| LFMD Average Weekly Movement | 19.9% |
| Healthcare Services Industry Average Movement | 11.6% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: LFMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: LFMD's weekly volatility has increased from 14% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 306 | Justin Schreiber | lifemd.com |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology.
LifeMD, Inc. Fundamentals Summary
| LFMD fundamental statistics | |
|---|---|
| Market cap | US$375.40m |
| Earnings (TTM) | -US$13.83m |
| Revenue (TTM) | US$234.01m |
1.6x
P/S Ratio-27.1x
P/E RatioIs LFMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFMD income statement (TTM) | |
|---|---|
| Revenue | US$234.01m |
| Cost of Revenue | US$28.11m |
| Gross Profit | US$205.90m |
| Other Expenses | US$219.73m |
| Earnings | -US$13.83m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 87.99% |
| Net Profit Margin | -5.91% |
| Debt/Equity Ratio | -4,692.5% |
How did LFMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 07:30 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LifeMD, Inc. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anderson Schock | B. Riley Securities, Inc. |
| Kyle Bauser | B. Riley Securities, Inc. |
| David Larsen | BTIG |